Federal judge nixes FDA’s lab-developed test rulenews2025-03-31T21:20:15+00:00March 31st, 2025|Endpoints News|
DC court sides with HHS in Vertex’s fertility program fightnews2025-03-31T19:57:10+00:00March 31st, 2025|Endpoints News|
Amgen loses challenge to Colorado drug review boardnews2025-03-28T19:35:47+00:00March 28th, 2025|Endpoints News|
J&J wins patent feud against Viatris over schizophrenia drugnews2025-03-28T17:05:43+00:00March 28th, 2025|Endpoints News|
FDA’s policy, communications staff likely to be among agency’s 3,500 staff cutsnews2025-03-27T18:55:01+00:00March 27th, 2025|Endpoints News|
AbbVie files suit against Genmab subsidiary ProfoundBionews2025-03-24T19:06:10+00:00March 24th, 2025|Endpoints News|
Trump think tank resurrects international drug pricing policynews2025-03-21T19:16:38+00:00March 21st, 2025|Endpoints News|
Gilead stock slips as HHS denies reports of HIV funding cutsnews2025-03-19T18:53:54+00:00March 19th, 2025|Endpoints News|
Trump’s DOJ rejects effort to shed mifepristone restrictionsnews2025-03-19T17:20:32+00:00March 19th, 2025|Endpoints News|
HHS extends administrative leave for probationary workers after court ordernews2025-03-18T18:03:53+00:00March 18th, 2025|Endpoints News|
